Form 4: Tandem Diabetes Care Executive Shannon Hansen Reports Stock Transactions

EVP & Chief Legal Officer of Tandem Diabetes Care, Shannon Hansen, reports multiple transactions involving company stock, including the vesting of restricted stock units and purchases through the employee stock purchase plan.

Summary

• Shannon Hansen, EVP & Chief Legal Officer at Tandem Diabetes Care, filed a Form 4 detailing changes in her beneficial ownership of company stock.
• The transactions occurred on November 15, 2024, and include the vesting of restricted stock units (RSUs) and the acquisition of shares through the employee stock purchase plan (ESPP).
• A total of 1,967 RSUs vested, resulting in the acquisition of 1,967 shares of common stock.
• 561 shares were acquired through the ESPP at a price of $15.64 per share.
• Shares were also withheld to cover tax obligations related to the vesting of RSUs, with 703 shares withheld at a price of $27.34 per share.
• After these transactions, Ms. Hansen directly owns 10,942 shares of common stock and indirectly owns 1,935 shares through a trust.

Sentiment

Score: 6

Explanation: The document reflects routine transactions and does not indicate any significant positive or negative sentiment. It is a standard regulatory filing.

Positives

• The vesting of RSUs indicates that performance milestones were likely met.
• Participation in the ESPP shows confidence in the company's future performance.

Negatives

• Shares were withheld to cover tax obligations, which reduces the total number of shares acquired.

Risks

• The sale of shares to cover tax obligations could potentially exert downward pressure on the stock price, although the number of shares is relatively small.
• Changes in executive ownership can sometimes be perceived negatively by the market, although these transactions are routine.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It reflects the standard practice of equity-based compensation and employee stock purchase plans.

Comparison to Industry Standards

• The vesting of RSUs and participation in ESPPs are standard compensation practices for executives in the biotechnology and medical device industries, similar to companies like Insulet and Dexcom.
• The tax withholding of shares is a common practice to cover tax liabilities associated with equity compensation, which is consistent with industry norms.
• The reporting of these transactions via Form 4 is a standard regulatory requirement for company insiders.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation.
• The withholding of shares for tax purposes may slightly reduce the number of shares available in the market.

Key Dates

Keywords

Tandem Diabetes Care, Stock Transactions, Form 4, Restricted Stock Units, Employee Stock Purchase Plan, Executive Ownership, Shannon Hansen